Display options
Share it on

Int J Endocrinol. 2014;2014:282489. doi: 10.1155/2014/282489. Epub 2014 Sep 03.

Adrenal disorders and the paediatric brain: pathophysiological considerations and clinical implications.

International journal of endocrinology

Vincenzo Salpietro, Agata Polizzi, Gabriella Di Rosa, Anna Claudia Romeo, Valeria Dipasquale, Paolo Morabito, Valeria Chirico, Teresa Arrigo, Martino Ruggieri

Affiliations

  1. Department of Pediatric Neurology, Chelsea and Westminster Hospital NHS Foundation Trust, 369 Fulham Road, London SW10 9NH, UK ; Unit of Genetics and Paediatric Immunology, Department of Pediatrics, University of Messina, Italy.
  2. National Center for Rare Diseases, Istituto Superiore di Sanità, Rome, Italy ; Institute of Neurological Sciences, National Research Council, Catania, Italy.
  3. Infantile Neuropsychiatry Unit, Department of Pediatrics, University of Messina, Italy.
  4. Unit of Genetics and Paediatric Immunology, Department of Pediatrics, University of Messina, Italy.
  5. Department of Clinical and Experimental Medicine and Pharmacology, University of Messina, Italy.
  6. Chair of Pediatrics, Department of Educational Sciences, University of Catania, Italy.

PMID: 25276129 PMCID: PMC4167812 DOI: 10.1155/2014/282489

Abstract

Various neurological and psychiatric manifestations have been recorded in children with adrenal disorders. Based on literature review and on personal case-studies and case-series we focused on the pathophysiological and clinical implications of glucocorticoid-related, mineralcorticoid-related, and catecholamine-related paediatric nervous system involvement. Childhood Cushing syndrome can be associated with long-lasting cognitive deficits and abnormal behaviour, even after resolution of the hypercortisolism. Exposure to excessive replacement of exogenous glucocorticoids in the paediatric age group (e.g., during treatments for adrenal insufficiency) has been reported with neurological and magnetic resonance imaging (MRI) abnormalities (e.g., delayed myelination and brain atrophy) due to potential corticosteroid-related myelin damage in the developing brain and the possible impairment of limbic system ontogenesis. Idiopathic intracranial hypertension (IIH), a disorder of unclear pathophysiology characterised by increased cerebrospinal fluid (CSF) pressure, has been described in children with hypercortisolism, adrenal insufficiency, and hyperaldosteronism, reflecting the potential underlying involvement of the adrenal-brain axis in the regulation of CSF pressure homeostasis. Arterial hypertension caused by paediatric adenomas or tumours of the adrenal cortex or medulla has been associated with various hypertension-related neurological manifestations. The development and maturation of the central nervous system (CNS) through childhood is tightly regulated by intrinsic, paracrine, endocrine, and external modulators, and perturbations in any of these factors, including those related to adrenal hormone imbalance, could result in consequences that affect the structure and function of the paediatric brain. Animal experiments and clinical studies demonstrated that the developing (i.e., paediatric) CNS seems to be particularly vulnerable to alterations induced by adrenal disorders and/or supraphysiological doses of corticosteroids. Physicians should be aware of potential neurological manifestations in children with adrenal dysfunction to achieve better prevention and timely diagnosis and treatment of these disorders. Further studies are needed to explore the potential neurological, cognitive, and psychiatric long-term consequences of high doses of prolonged corticosteroid administration in childhood.

References

  1. Endocr Dev. 2013;24:86-95 - PubMed
  2. Neuro Endocrinol Lett. 2012;33(6):569-73 - PubMed
  3. J Clin Endocrinol Metab. 2010 Dec;95(12):5348-56 - PubMed
  4. Am J Obstet Gynecol. 2004 Jul;191(1):217-24 - PubMed
  5. Arch Neurol. 2006 Mar;63(3):413-6 - PubMed
  6. J Clin Endocrinol Metab. 2002 May;87(5):1949-54 - PubMed
  7. Physiol Rev. 2011 Jan;91(1):177-219 - PubMed
  8. Eur J Pediatr. 2009 Feb;168(2):237-40 - PubMed
  9. Am J Emerg Med. 2010 Mar;28(3):386.e3-5 - PubMed
  10. Headache. 2008 Sep;48(8):1237-9 - PubMed
  11. Lancet Neurol. 2010 Sep;9(9):933-40 - PubMed
  12. N Engl J Med. 2007 Sep 20;357(12):1190-8 - PubMed
  13. J Am Soc Nephrol. 1994 Feb;4(8):1522-30 - PubMed
  14. Clin Perinatol. 2014 Mar;41(1):191-208 - PubMed
  15. Endocr Rev. 1998 Jun;19(3):269-301 - PubMed
  16. J Pediatr Endocrinol Metab. 2014 Jan;27(1-2):107-15 - PubMed
  17. Psychoneuroendocrinology. 2008 Feb;33(2):238-45 - PubMed
  18. Clin Pediatr (Phila). 1997 Dec;36(12):711-3 - PubMed
  19. Clin Endocrinol (Oxf). 1993 Mar;38(3):245-51 - PubMed
  20. Curr Opin Pediatr. 2014 Aug;26(4):480-6 - PubMed
  21. Can J Neurol Sci. 1996 May;23(2):141-4 - PubMed
  22. Clin Pediatr Endocrinol. 2013 Oct;22(4):77-81 - PubMed
  23. Hypertension. 1986 Feb;8(2):93-102 - PubMed
  24. Cancer Res. 1996 Mar 15;56(6):1352-60 - PubMed
  25. Pediatr Clin North Am. 2014 Jun;61(3):579-90 - PubMed
  26. Neurotoxicology. 1993 Spring;14(1):83-144 - PubMed
  27. Am J Obstet Gynecol. 2004 Mar;190(3):588-95 - PubMed
  28. Korean J Radiol. 2013 Sep-Oct;14(5):849-53 - PubMed
  29. Lancet. 2014 Jun 21;383(9935):2152-67 - PubMed
  30. Pediatrics. 2013 Dec;132(6):e1709-14 - PubMed
  31. Lancet. 2005 Jun 18-24;365(9477):2125-36 - PubMed
  32. Int J Endocrinol. 2014;2014:794187 - PubMed
  33. J Child Neurol. 2010 Oct;25(10):1269-71 - PubMed
  34. Yale J Biol Med. 1993 Jul-Aug;66(4):277-314 - PubMed
  35. Arch Dis Child Fetal Neonatal Ed. 2009 Nov;94(6):F402-6 - PubMed
  36. Neurochem Res. 1984 Mar;9(3):333-50 - PubMed
  37. Pediatrics. 2011 Jun;127(6):e1610-4 - PubMed
  38. Med Clin North Am. 1997 May;81(3):585-609 - PubMed
  39. J Clin Endocrinol Metab. 1998 Jul;83(7):2244-54 - PubMed
  40. J Clin Endocrinol Metab. 2005 Jun;90(6):3243-50 - PubMed
  41. J Pediatr Endocrinol Metab. 2013;26(1-2):13-7 - PubMed
  42. Pediatr Res. 2012 Jun;71(6):661-7 - PubMed
  43. J Endocrinol Invest. 2002 Feb;25(2):181-94 - PubMed
  44. J Clin Endocrinol Metab. 2003 Apr;88(4):1760-5 - PubMed
  45. Neurology. 2008 Jun 3;70(23):2248-51 - PubMed
  46. Ann N Y Acad Sci. 1994 Nov 30;746:294-304; discussion 304-7 - PubMed
  47. Med Princ Pract. 2005 Mar-Apr;14(2):115-7 - PubMed
  48. Proc Natl Acad Sci U S A. 1996 Apr 30;93(9):3908-13 - PubMed
  49. Arch Pediatr. 2008 Oct;15(10):1531-4 - PubMed
  50. Eur J Endocrinol. 2013 Mar 15;168(4):631-8 - PubMed
  51. J Comput Assist Tomogr. 1978 Jan;2(1):16-23 - PubMed
  52. Autoimmun Rev. 2014 Apr-May;13(4-5):408-11 - PubMed
  53. Handb Clin Neurol. 2014;120:749-71 - PubMed
  54. Eur Neurol. 2002;47(1):3-10 - PubMed
  55. J Hypertens. 2012 Mar;30(3):629-30 - PubMed
  56. Science. 2009 Nov 6;326(5954):818-23 - PubMed
  57. Indian J Endocrinol Metab. 2013 Jan;17(1):121-7 - PubMed
  58. Pediatrics. 2010 Nov;126(5):e1045-55 - PubMed
  59. Curr Hypertens Rep. 2012 Dec;14(6):573-80 - PubMed
  60. J Clin Neurosci. 2007 Jul;14(7):684-8 - PubMed
  61. J Neurosci. 2001 Jan 1;21(1):330-9 - PubMed
  62. Obstet Gynecol. 2009 Jan;113(1):142-151 - PubMed
  63. Pharmacopsychiatry. 1992 Jul;25(4):192-8 - PubMed
  64. J Biochem. 2009 Dec;146(6):917-23 - PubMed
  65. Am J Med Sci. 2013 Sep;346(3):194-8 - PubMed
  66. Arch Dis Child. 2005 May;90(5):500-6 - PubMed
  67. Endocrinol Metab Clin North Am. 2012 Dec;41(4):793-803 - PubMed
  68. Neuropediatrics. 2013 Oct;44(5):239-44 - PubMed
  69. J Clin Invest. 2008 Jul;118(7):2496-505 - PubMed
  70. Ann Endocrinol (Paris). 2007 Dec;68(6):403-11 - PubMed
  71. G Ital Nefrol. 2004 Mar-Apr;21(2):139-43 - PubMed
  72. Horm Res Paediatr. 2014;81(4):217-25 - PubMed
  73. N Engl J Med. 1994 Sep 8;331(10):629-36 - PubMed
  74. J Pediatr Orthop. 1999 May-Jun;19(3):301-5 - PubMed
  75. Clin Lab. 2002;48(3-4):181-90 - PubMed
  76. Compr Physiol. 2014 Jul;4(3):1083-119 - PubMed
  77. Semin Nephrol. 2013 May;33(3):300-9 - PubMed
  78. An Pediatr (Barc). 2003 Apr;58(4):376-80 - PubMed
  79. Neurotoxicology. 2000 Feb-Apr;21(1-2):15-36 - PubMed
  80. BMC Neurol. 2006 Sep 10;6:33 - PubMed
  81. Arch Dermatol Res. 2011 Jul;303(5):317-25 - PubMed
  82. AJNR Am J Neuroradiol. 1997 Jan;18(1):101-6 - PubMed
  83. J Child Neurol. 2001 Jun;16(6):458-61 - PubMed
  84. Horm Res. 1998;50(2):83-8 - PubMed
  85. J Endocrinol Invest. 2009 May;32(5):482-3 - PubMed
  86. J Clin Endocrinol Metab. 2012 Feb;97(2):663-71 - PubMed
  87. Steroids. 1996 Apr;61(4):193-6 - PubMed
  88. Dev Neuropsychol. 2011;36(4):473-92 - PubMed
  89. Headache. 2014 Jul-Aug;54(7):1229 - PubMed
  90. Hypertension. 2014 Apr;63(4):648-54 - PubMed
  91. Am J Med Genet. 1998 Apr 13;76(5):415-9 - PubMed
  92. J Urol. 1999 Nov;162(5):1582-6 - PubMed
  93. J Clin Endocrinol Metab. 2005 May;90(5):2531-6 - PubMed
  94. Br Med J. 1980 Jul 12;281(6233):113 - PubMed
  95. Br J Surg. 2009 Dec;96(12):1381-92 - PubMed
  96. Brain Dev. 2009 Aug;31(7):558-61 - PubMed
  97. J Neurol. 2014 Mar;261(3):451-60 - PubMed
  98. Clin Lab Sci. 2013 Spring;26(2):118-25 - PubMed
  99. J Pediatr. 2013 May;162(5):1084 - PubMed
  100. Environ Health Perspect. 2000 Jun;108 Suppl 3:511-33 - PubMed
  101. Clin Endocrinol (Oxf). 2013 Oct;79(4):537-44 - PubMed
  102. J Child Neurol. 1997 Apr;12(3):181-6 - PubMed
  103. Neurogenetics. 2013 May;14(2):89-98 - PubMed
  104. Childs Nerv Syst. 1999 Jul;15(6-7):295-308 - PubMed
  105. BMJ Case Rep. 2010 May 11;2010: - PubMed
  106. JAMA. 2003 Aug 20;290(7):905-11 - PubMed
  107. QJM. 1996 Jul;89(7):543-51 - PubMed
  108. Fam Cancer. 2005;4(1):25-36 - PubMed
  109. J Neurol Sci. 2011 Jul 15;306(1-2):91-3 - PubMed
  110. N Engl J Med. 2007 Sep 20;357(12):1179-89 - PubMed
  111. Orphanet J Rare Dis. 2012 Aug 13;7:51 - PubMed
  112. J Clin Endocrinol Metab. 2011 Jun;96(6):E925-8 - PubMed
  113. Arch Dis Child. 1993 Jun;68(6):779-82 - PubMed
  114. Am J Ophthalmol. 1993 Nov 15;116(5):650-1 - PubMed
  115. Pediatr Nephrol. 2011 Oct;26(10):1789-802 - PubMed
  116. Am J Med. 1990 Feb;88(2):161-6 - PubMed

Publication Types